QT Imaging Holdings, Inc. (QTI): R&D Expense
$3.94M
Year ended 2025-12-31
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $3.94M | +20.5% | 2026-03-25, From 2025-01-01 |
| 2024-12-31 | $3.27M | +119.9% | 2026-03-25, From 2024-01-01 |
| 2023-12-31 | $1.49M | n/a | 2025-03-31, From 2023-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| QT Imaging Holdings, Inc. (QTI) | 2025-12-31 | $3.94M | +20.5% |
| Precision Optics Corporation, Inc. (POCI) | 2025-06-30 | $1.16M | +17.9% |
| Hyperfine, Inc. (HYPR) | 2025-12-31 | $17.45M | -22.4% |
| CapsoVision, Inc (CV) | 2025-12-31 | $18.31M | +21.1% |
| Escalon Medical Corp (ESMC) | 2025-06-30 | $753.1K | +9.4% |
| electroCore, Inc. (ECOR) | 2024-12-31 | $2.36M | -55.6% |
| Stereotaxis, Inc. (STXS) | 2025-12-31 | $9.38M | -3.9% |
| Nuwellis, Inc. (NUWE) | 2025-12-31 | $2.71M | -15.5% |
| Iridex Corp (IRIX) | 2026-01-03 | $3.67M | -32.7% |
Compare QTI, POCI, HYPR, CV side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗